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  Middle cerebral artery-peak systolic velocity (MCA-PSV) has been reported to 6 
predict fetal anemia with similar accuracy as amniotic ∆OD450 assay.  Alloimmunized 7 
dizygotic twin pregnancy allows us to compare anemic and non-anemic twins in the 8 
same intrauterine environment.  We herein present a case of Rh (E)-incompatible 9 
dizygotic twin pregnancy, where MCA-PSV could precisely detect the anemia in one of 10 
the twins.  A 36-year-old woman, whose previous child required exchange transfusion 11 
due to hemolytic anemia of newborn (HFDN), conceived twins after in vitro 12 
fertilization-embryo transfer.  At 24 weeks’ gestation, MCA-PSV of twin A and twin B 13 
were 23.9 cm/s (0.8 multiples of median: MoM) and 30.7 cm/s (1.0 MoM), respectively.  14 
At 31 weeks’ gestation, MCA-PSV values of both twins were sharply elevated to nearly 15 
1.4 MoM.  Thereafter, MCA-PSV of twin A fell to 1.0 MoM, whereas MCA-PSV of 16 
twin B exceeded 1.5 MoM at 34 weeks’ gestation.  Development of fetal anemia was 17 
suspected and emergency cesarean section was performed. Twin B that showed 18 
moderate anemia with positive direct Coombs’ test was diagnosed as HFDN due to 19 
anti-E alloimmunization.  Twin B required phototherapy and red cell transfusion, but 20 
exchange transfusion was safely obviated. 21 
 22 





  The first step of the management of alloimmunized pregnancies is serial 3 
measurement of maternal irregular antibody titers.  Once the titer elevates beyond 4 
critical level (usually >1:32), paternal evaluation should be indicated 1.  If the patient’s 5 
partner is negative for the particular red cell antigen, then the further evaluation of the 6 
fetus is unnecessary.  If paternal blood type is positive for the antigen, the next step 7 
usually necessitates fetal evaluation for possible anemia.  The main approach for the 8 
prediction of fetal anemia has been amniocentesis to measure bilirubin concentration in 9 
the amniotic fluid through ∆OD450 assay. 10 
  In 2000, Mari et al. reported that Doppler measurement of fetal middle cerebral artery 11 
peak systolic velocity (MCA-PSV) is highly predictive for fetal anemia caused by red 12 
cell alloimmunization 2.  They found that MCA-PSV of >1.5 multiples of median 13 
(MoM) corresponds to moderate to severe fetal anemia.  Elevated MCA-PSV seen in 14 
fetal anemia is likely to result from increased cardiac output and decreased blood 15 
viscosity.  Although theoretically velocities of all fetal vessels should be increased, the 16 
MCA is suitable for the quantification because its position frequently permits a low 17 
angle of insonation.  Afterwards, many investigators verified the usefulness of 18 
MCA-PSV 3-5 and increasing number of obstetricians come to believe that MCA-PSV 19 
measurement could safely replace invasive amniocentesis in the management of 20 
alloimmunized pregnancies. 21 
  For women who previously delivered neonate with hemolytic anemia, the maternal 22 
antibody titer does not necessarily reflect the risk for the development of fetal anemia.   23 
As a result, repetitive amniocentesis used to be the only option to monitor such fetuses 1.  24 
Amniocentesis is more difficult and requires more skilled technique in multiple 25 
pregnancies than in singleton pregnancies.  In this respect, introduction of MCA-PSV 26 
could be of particular benefit in multiple pregnancies of women who previously 27 
delivered the affected neonate.  Recently, Dashe et al. reported that MCA-PSV values 28 
in uncomplicated twins are comparable to published singleton norms 6.  Nevertheless 29 
there have been only few case reports where measurement of MCA-PSV is actually 30 
applied to alloimmunized twin pregnancies 7. 31 
 Here, we report a case of Rh (E)-incompatible dizygotic twin pregnancy where 32 




Case Report 1 
 2 
  A 36-year-old woman (gravida 2, prara 2) conceived dizygotic twins following in 3 
vitro fertilization-embryo transfer.  Her first pregnancy ended in intrauterine fetal 4 
demise at 39 weeks’ gestation for unknown cause.  During her second pregnancy, her 5 
serum anti-E antibody titer arose from 1:8 (32 weeks’ gestation) to 1:64 (36 weeks’ 6 
gestation) and a mature female baby was vaginally born at 38 weeks’ gestation.  The 7 
baby showed moderate anemia (hemoglobin=9.2 g/dl) with hyperbilirubinemia (total 8 
bilirubin=4.9 mg/dl) at birth, leading to diagnosis of hemolytic anemia of newborn 9 
(HFDN).  Total bilirubin arose to 11.9 mg/dl after 12 hours and exchange transfusion 10 
was instituted. 11 
  The blood type of the patient was Rh (CCDee) and that of the spouse was Rh 12 
(CcDEe).  Thus, theoretically Rh (E)- or Rh (c)-incompatibility could exist between 13 
the mother and the twins.  For a woman whose previous child was affected, maternal 14 
antibody titer does not necessarily reflect fetal anemia 1.  Therefore, we monitored 15 
MCA-PSV for each twin.  At 24 weeks’ gestation, maternal anti-E titer was 1:16 and 16 
anti-c was undetectable.  MCA-PSV of twin A and twin B were 23.9 cm/s (0.8 MoM) 17 
and 30.7 cm/s (1.0 MoM), respectively.  Maternal anti-E titer fluctuated between 1:8 18 
and 1:32 with highest titer observed at 26 weeks’ gestation.  Anti-c titer remained 19 
undetectable throughout the pregnancy.  Serial changes in MCA-PSV of twin A and B 20 
are shown in Figure 1.  At 31 weeks’ gestation, MCA-PSV values of both twins were 21 
sharply elevated to nearly 1.4 MoM.  Betamethasone was administered to the mother 22 
for prevention of neonatal respiratory distress syndrome.  MCA-PSV of twin A fell to 23 
1.0 MoM thereafter, whereas increased MCA-PSV (≒1.4MoM) of twin B persisted and 24 
exceeded 1.5 MoM, which corresponds to moderate anemia, at 34 weeks’ gestation.  25 
Considering the gestational age, instead of verifying fetal anemia with invasive 26 
amniocentesis or cordocentesis, emergency cesarean section was selected.  27 
  Twin A was a female baby weighing 1644 g and had Apgar scores of 8 at 1 minute 28 
and 9 at 5 minutes with umbilical artery pH of 7.359.  Twin B was a male baby 29 
weighing 2070 g and had Apgar scores of 8 at 1 minute and 10 at 5 minutes with 30 
umbilical artery pH of 7.337.  Umbilical venous blood showed hemoglobin of 12.9 31 
g/dl (normal) for twin A and 7.6 g/dl (moderate anemia) for twin B.  Rh type of twin A 32 
and B proved to be CCDee (same as the mother) and CcDEe (same as the father), 33 
 5 
respectively.  Amniotic sample was collected from each twin at the time of cesarean 1 
section.  ∆OD450 values plotted on Liley’s chart showed that twin A was within zone 1 2 
(no anemia) and twin B was within zone 2 (moderate anemia) 8. 3 
  Initial laboratory data from twin A and B were shown in Table 1.  Twin B with 4 
positive direct Coombs’ test and moderate hyperbilirubinemia was diagnosed as HFDN 5 
due to Rh (E) incompatibility.  Postnatal course of twin A was uneventful.  Twin B 6 






  It is known that maternal antibody titer does not necessarily reflect fetal anemia for 3 
women who previously delivered neonate with hemolytic disease 1.  In fact, maternal 4 
anti-E titer fluctuated but never exceeded the critical level (1:32).  In such cases, 5 
repetitive amniocentesis used to be the only way to predict fetal anemia.  Amniotic 6 
sample collected at the time of cesarean section showed that ∆OD450 value of twin A 7 
was within zone 1 (normal) and that of twin B was within zone 2 (moderate anemia).  8 
Thus, non-invasive Doppler measurement of MCA-PSV could be an alternative to 9 
invasive amniocentesis in the management of alloimmunized twin pregnancies.  10 
  For the detection of moderate to severe fetal anemia, positive predictive values of 11 
MCA-PSV measurement reported in the past studies are 53-80% 2-5.  In other words, 12 
20-47% of the fetuses with MCA-PSV>1.5 MoM were not actually anemic.  The false 13 
positive might result from 1) factors other than fetal anemia that increase MCA-PSV 14 
and/or 2) measurement variability that often accompanies new methodology.  15 
Increased MCA-PSV is encountered in some of intrauterine growth restricted (IUGR) 16 
fetuses without anemia 9.  In IUGR, redistribution of the blood flow from the periphery 17 
to the brain could be manifested as increased MCA-PSV and decreased descending 18 
aorta-PSV (DAO-PSV).  In contrast, fetal anemia causes elevation in velocities of all 19 
fetal vessels due to increased cardiac output and decreased blood viscosity.  Thus, 20 
combined use of MCA-PSV and DAO-PSV can decrease the false positive rate 10.  21 
High MCA-PSV due to measurement variability could also lead to unnecessary medical 22 
intervention.  However, fetal anemia caused by alloimmunization is usually a chronic 23 
progressive disease that should induce continuous increase in MCA-PSV.  In the 24 
present case, we encountered sharp increase in MCA-PSV of both twins at 31 weeks’ 25 
gestation.  Daily assessment of MCA-PSV revealed that increase of MCA-PSV in twin 26 
A was temporary.  In contrast, there was consistent increase in the MCA-PSV of twin 27 
B, who proved to be actually anemic.  Thus, when abnormally increased MCA-PSV is 28 
observed, daily measurement and/or combined measurement of DAO-PSV may be 29 
helpful to rule out false positive and to minimize unnecessary medical intervention. 30 
  In conclusion, we presented here a case of Rh (E)-incompatible dizygotic twin 31 
pregnancy.  Since her previous child was affected, serial maternal titer assessment was 32 
considered to be inadequate for the surveillance of fetal anemia.  In such cases, 33 
 7 
monitoring of MCA-PSV could be a useful alternative to reduce the requirement of 1 
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Figure legends 1 
 2 
Figure 1. Serial changes in middle cerebral artery-peak systolic velocity (MCA-PSV) 3 
for twin A and twin B 4 
 MCA-PSV values at each gestational week for twin A (closed square) and twin B 5 
(open square) are plotted on a Mari’s chart 2.  The dotted line indicates the median 6 
MCA-PSV in normal pregnancies, and the solid line 1.5 multiples of the median.  The 7 
solid arrows indicate timing of maternal betamethasone injections.  The open arrow 8 





Table 1. Laboratory data (Blood samples taken at 30 minutes after birth) 3 
 Twin A Twin B 
White Blood Cell (x109/L) 10.8 10.1 
Hemoglobin (g/dl) 14.7 9.7 
Hematocrit (%) 46.5 30.3 
Platelet (x109/L) 312 299 
Toatal Protein (g/dl) 4.6 5.0 
Albumin (g/dl) 3.0 3.4 
Total Bilirubin (mg/dl) 1.6 3.7 
Direct Coombs’ test (-) (+) 
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